chr20-10405486-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The ENST00000347364.7(MKKS):c.1474G>A(p.Asp492Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000728 in 1,614,214 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D492H) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000347364.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MKKS | NM_170784.3 | c.1474G>A | p.Asp492Asn | missense_variant | 6/6 | ENST00000347364.7 | NP_740754.1 | |
MKKS | NM_018848.3 | c.1474G>A | p.Asp492Asn | missense_variant | 6/6 | NP_061336.1 | ||
MKKS | NR_072977.2 | n.835G>A | non_coding_transcript_exon_variant | 5/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MKKS | ENST00000347364.7 | c.1474G>A | p.Asp492Asn | missense_variant | 6/6 | 1 | NM_170784.3 | ENSP00000246062 | P1 | |
MKKS | ENST00000399054.6 | c.1474G>A | p.Asp492Asn | missense_variant | 6/6 | 1 | ENSP00000382008 | P1 | ||
MKKS | ENST00000651692.1 | c.1474G>A | p.Asp492Asn | missense_variant | 7/7 | ENSP00000498849 | P1 | |||
MKKS | ENST00000652676.1 | n.1118G>A | non_coding_transcript_exon_variant | 7/7 |
Frequencies
GnomAD3 genomes AF: 0.000401 AC: 61AN: 152222Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000302 AC: 76AN: 251406Hom.: 0 AF XY: 0.000250 AC XY: 34AN XY: 135874
GnomAD4 exome AF: 0.000762 AC: 1114AN: 1461874Hom.: 0 Cov.: 32 AF XY: 0.000722 AC XY: 525AN XY: 727234
GnomAD4 genome AF: 0.000400 AC: 61AN: 152340Hom.: 0 Cov.: 32 AF XY: 0.000255 AC XY: 19AN XY: 74504
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | May 01, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 10, 2013 | - - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jun 26, 2018 | - - |
McKusick-Kaufman syndrome;C1858054:Bardet-Biedl syndrome 6 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 16, 2022 | - - |
MKKS-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 24, 2024 | The MKKS c.1474G>A variant is predicted to result in the amino acid substitution p.Asp492Asn. This variant was identified in the heterozygous state in a patient with Bardet-Biedl syndrome; however, a second plausible pathogenic variant was not identified in the reported individual (Fauser et al. 2003. PubMed ID: 12920096). It was also reported as a potential compound heterozygous variant in a study of healthy adults carrying candidate pathogenic variants in genes related to kidney and genitourinary disorders (Rasouly et al. 2018. PubMed ID: 30476936, Table S4). In vivo studies suggest that this variant may function as a null allele (Zaghloul et al. 2010. PubMed ID: 20498079, Table S5). This variant is reported in 0.063% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Bardet-Biedl syndrome;C0948368:McKusick-Kaufman syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 17, 2022 | This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 492 of the MKKS protein (p.Asp492Asn). This variant is present in population databases (rs142327258, gnomAD 0.06%). This missense change has been observed in individual(s) with Bardet-Biedl syndrome (PMID: 12920096). ClinVar contains an entry for this variant (Variation ID: 95921). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MKKS protein function. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on MKKS function (PMID: 20498079). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
McKusick-Kaufman syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Bardet-Biedl syndrome 6 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at